XML 31 R37.htm IDEA: XBRL DOCUMENT

Collaboration and Other Agreements - Collaboration and License Agreement with Janssen Biotech, Inc (Details Narrative 1) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2012	Jun. 30, 2011
Deferred revenue - non-current portion	$ 67,324
Collaboration and License Agreement with Janssen Biotech, Inc (Janssen)
Deferred revenue Total Under Janssen Agreement	75,378
Deferred revenue - non-current portion	$ 67,324

The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References+ Details